Cargando…

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study

OBJECTIVE: To estimate benefits and harms of different colorectal cancer screening strategies, stratified by (baseline) 15-year colorectal cancer risk. DESIGN: Microsimulation modelling study using MIcrosimulation SCreening ANalysis-Colon (MISCAN-Colon). SETTING: A parallel guideline committee (BMJ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buskermolen, Maaike, Cenin, Dayna R, Helsingen, Lise M, Guyatt, Gordon, Vandvik, Per Olav, Haug, Ulrike, Bretthauer, Michael, Lansdorp-Vogelaar, Iris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774435/ https://www.ncbi.nlm.nih.gov/pubmed/31578177 http://dx.doi.org/10.1136/bmj.l5383

Ejemplares similares

Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis
por: Jodal, Henriette C, et al.
Publicado: (2019)

The impact of information about different absolute benefits and harms on intention to participate in colorectal cancer screening: A think-aloud study and online randomised experiment
por: Usher-Smith, Juliet A., et al.
Publicado: (2021)

Optimizing Patient Risk Stratification for Colonoscopy Screening and Surveillance of Colorectal Cancer: The Role for Linked Data
por: Preen, David B., et al.
Publicado: (2017)

Characteristics of nonparticipants in a randomised colorectal cancer screening trial comparing sigmoidoscopy and faecal immunochemical testing
por: Botteri, Edoardo, et al.
Publicado: (2022)

Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2019)

Establishing thresholds for important benefits considering the harms of screening interventions
por: Helsingen, Lise Mørkved, et al.
Publicado: (2020)

Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe
por: Gini, Andrea, et al.
Publicado: (2021)

Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
por: van der Vlugt, Manon, et al.
Publicado: (2017)

Estimation of overdiagnosis in colorectal cancer screening with sigmoidoscopy and faecal occult blood testing: comparison of simulation models
por: Wieszczy, Paulina, et al.
Publicado: (2021)

FIT for colonoscopy: Benefits of the faecal immunochemical test for triaging symptomatic patients
por: Symonds, Erin L., et al.
Publicado: (2022)

Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy
por: Sharp, L, et al.
Publicado: (2012)

Optimising colorectal cancer screening in Shanghai, China: a modelling study
por: Cenin, Dayna, et al.
Publicado: (2022)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

Gastroscopy after positive screening for faecal immunochemical tests and colonoscopy: A systematic review
por: Choe, Lina, et al.
Publicado: (2023)

Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
por: van de Schootbrugge-Vandermeer, Hilliene J., et al.
Publicado: (2023)

Cost-effectiveness analysis of colorectal cancer screening in Shanghai, China: A modelling study
por: Wang, Jie, et al.
Publicado: (2022)

The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy
por: Wong, Martin CS, et al.
Publicado: (2015)

Factors predicting improved compliance towards colonoscopy in individuals with positive faecal immunochemical test (FIT)
por: Lim, Tian‐Zhi, et al.
Publicado: (2021)

Accuracy of a faecal immunochemical test in patients under colonoscopy surveillance of colorectal adenoma and cancer
por: Olsson, Louise, et al.
Publicado: (2023)

Cost‐effectiveness of prophylactic hysterectomy in first‐degree female relatives with Lynch syndrome of patients diagnosed with colorectal cancer in the United States: a microsimulation study
por: Alblas, Maaike, et al.
Publicado: (2021)

Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening
por: Iovanescu, Dana, et al.
Publicado: (2016)

Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study
por: Terhaar sive Droste, Jochim S, et al.
Publicado: (2012)

Conversion of colonoscopy to flexible sigmoidoscopy: an unintended consequence of quality measurement in endoscopy
por: Thompson, Chris, et al.
Publicado: (2016)

Evaluation of Colonoscopy and Sigmoidoscopy Utilization for Colorectal Cancer Screening in Georgia, USA
por: Ansa, Benjamin E., et al.
Publicado: (2022)

Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test
por: Pin-Vieito, Noel, et al.
Publicado: (2020)

Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review
por: Ali, Omar, et al.
Publicado: (2022)

Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemic
por: Lincoln, Anne G, et al.
Publicado: (2023)

Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing
por: van der Meulen, Miriam P., et al.
Publicado: (2022)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
por: Cenin, Dayna R, et al.
Publicado: (2018)

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study
por: de Jonge, Lucie, et al.
Publicado: (2021)

Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer
por: Zorzi, Manuel, et al.
Publicado: (2022)

Correction to: Two sides of every coin: individuals’ experiences of undergoing colorectal cancer screening by faecal immunochemical test and colonoscopy
Publicado: (2022)

Possible Value of Faecal Immunochemical Test (FIT) When Added in Symptomatic Patients Referred for Colonoscopy: A Systematic Review
por: Brands, Henrike Jacoba, et al.
Publicado: (2023)

Erratum to: Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemic
Publicado: (2023)

Unequal Recovery in Colorectal Cancer Screening Following the COVID-19 Pandemic: A Comparative Microsimulation Analysis
por: de Lima, Pedro Nascimento, et al.
Publicado: (2022)

Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial
por: Hoff, Geir, et al.
Publicado: (2009)

Early Sigmoidoscopy or Colonoscopy Is Associated With Improved Hospital Outcomes in Ulcerative Colitis-Related Hospitalization
por: Obi, Kenneth, et al.
Publicado: (2016)

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
por: Kooyker, Arthur I., et al.
Publicado: (2020)

Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study
por: Cross, Amanda J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9j8os67uita6lemfvukmdtpdcj